How can dilncRNA-mediated condensate formation be distinguished from physiological DDR condensates?
RESOLVED
All therapeutic approaches require selectively targeting pathological condensates while preserving normal DNA repair. The debate identified this selectivity challenge but provided no mechanistic basis for discrimination between beneficial and harmful condensates.
Source: Debate session sess_SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca (Analysis: SDA-2026-04-08-gap-pubmed-20260406-062229-35a642ca)
Priority: 0.85Domain: cell biologyHypotheses: 0
📊 Landscape Analysis
Landscape Summary:
How can dilncRNA-mediated condensate formation be distinguished from physiological DDR condensates? is a 0.85 priority gap in cell biology.
It has 0 linked hypotheses with average composite score 0.837.
Status: resolved.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?
Key Researchers
Colonna, Sevlever, et al. (TREM2 biology)
Clinical Trials
How can dilncRNA-mediated condensate formation be distinguished from physiological DDR condensates? — INVOKE-2 (completed)